OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 84 citing articles:

Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment
Richard Salvador, Carla Moutinho, Carla Silva, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 399-399
Open Access

Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access

Embracing the second chance: efficacy and safety of revisional bariatric surgery for weight regain
Graham J. Spurzem, Ryan C. Broderick, Estella Y. Huang, et al.
Mini-invasive Surgery (2025)
Open Access

Hyperphagia in Bardet–Biedl syndrome: Pathophysiology, burden, and management
Philip L. Beales, Metin Cetiner, Andrea M. Haqq, et al.
Obesity Reviews (2025)
Open Access

Long-Term Trajectories of Left Heart Geometry, Mechanics, and Oxygen Demand After Bariatric Surgery
L M D Grymyr, Saied Nadirpour, Eva Gerdts, et al.
Circulation Heart Failure (2025)
Closed Access

Glucagon-like peptide-1 receptor agonists for post-bariatric surgery weight regain and insufficient weight loss: A systematic review
Kevin Gracia Pratama, Heri Nugroho, Antoninus Hengky, et al.
Obesity Medicine (2024) Vol. 46, pp. 100533-100533
Closed Access | Times Cited: 4

Adjuvant and Neo-Adjuvant Anti-Obesity Medications and Bariatric Surgery: A Scoping Review
Theo Sher, Michelle Y. McGee, Christopher DuCoin, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 2, pp. 377-402
Closed Access | Times Cited: 4

Semaglutide for weight loss: unanswered questions
Ploutarchos Tzoulis, Stephanie Baldeweg
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4

Integrating Pharmacotherapy and Psychotherapy for Weight Loss
Marla Sanzone, Morgan T. Sammons
Journal of Health Service Psychology (2024)
Closed Access | Times Cited: 3

Weight Regain after Metabolic Surgery: Beyond the Surgical Failure
Juan Salazar, Pablo Durán, Bermary Garrido, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1143-1143
Open Access | Times Cited: 3

Outcomes and Management of Re-Establishing Bariatric Patients
Pourya Medhati, Omnia S Saleh, Abdelrahman Nimeri, et al.
Journal of the American College of Surgeons (2024) Vol. 238, Iss. 6, pp. 1035-1043
Closed Access | Times Cited: 3

GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report
Fionnuala Crowley, Stav Brown, Emily J. Gallagher, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3

New Generation Anti-Obesity Pharmacotherapy: Companion or Competitor to Metabolic Bariatric Surgery?
Amirhossein Sahebkar, Kishore M. Gadde, Matthew Kroh, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104072-104072
Closed Access | Times Cited: 3

Obesity treatment in adolescents and adults in the era of personalized medicine
Magnus Sundbom, Kajsa Järvholm, Lovisa Sjögren, et al.
Journal of Internal Medicine (2024) Vol. 296, Iss. 2, pp. 139-155
Open Access | Times Cited: 3

The role of incretin receptor agonists in the treatment of obesity
Thomas Först, Christophe De Block, Stefano Del Prato, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4178-4196
Open Access | Times Cited: 3

Incretin-based therapies for the treatment of obesity-related diseases
Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3

How to address weight regain after bariatric surgery in an individualized way
Ricardo V. Cohen, Tarissa BZ Petry
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 5, pp. 993-1002
Closed Access | Times Cited: 8

Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial
Cláudia Matta-Coelho, Laurence J. Dobbie, James P. Crane, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 11, pp. 1132-1142
Open Access | Times Cited: 7

Practical guide: Glucagon-like peptide-1 and dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonists in diabetes mellitus
Saleh Fahad Alqifari, Omar Al Komi, Abdullah Esmail, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 331-347
Open Access | Times Cited: 2

Scroll to top